Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.
From the official U.S. FDA label for Regalgan Tablets## (strength format), the active ingredient registered with NAFDAC.
See symptoms on front panel. Relieves dry cough with hypersensitivity to cold *
symptoms persist for more than 3 days or worsen.
If pregnant or breast-feeding, ask a health professional before use.
Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.
Regalgan Tablets## (strength format) contains Pitofenone Hydrochloride; Fenpiverinium Bromide; Acetaminophen (5mg; 0.1mg; 500mg), as tablet, according to its NAFDAC registration record.
Yes. Regalgan Tablets## (strength format) is listed on the NAFDAC register under registration number B4-0792, and its registration is active as of 5 November 2026.
No WHO falsified or substandard medical product alert currently matches Regalgan Tablets## (strength format) in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number B4-0792, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
See symptoms on front panel. Relieves dry cough with hypersensitivity to cold * (Summarised from the official U.S. FDA label for Regalgan Tablets## (strength format). Always follow your doctor or pharmacist.)
Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.